Life Science Insights
RECRUITMENT TRENDS
INDUSTRY NEWS
We're almost half way through 2023 already! And, although funding within the life science industry as been unstable, we have still seen some impressive scientific advancements worth mentioning.
?
Scientists create CRISPR-based drug candidate targeting the microbiome
A new drug candidate targeting E. coli in the gut is in phase 1 clinical trials. According to a new paper it may improve the well-being of blood cancer patients and reduce their mortality rate from E. coli infections.?read more...
?
FDA-approved Alzheimer's drug lecanemab could prevent free-floating amyloid beta fibrils from damaging the brain
Researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. Scientists showed the small aggregates of the amyloid beta protein could float through the brain tissue fluid, reaching many brain regions and disrupting local neuron functioning.?read more...
?
Reviving a forgotten antibiotic: Old drug shows new promise against superbugs
An old antibiotic may provide much-needed protection against multi-drug resistant bacterial infections, according to a new study published May 16th?in the open access journal?PLOS Biology?by James Kirby of Harvard Medical School, US, and colleagues.?read more...?
HIGHLIGHTING OUR SUCCESS